Metraipolis › archive › dc_4c141c5309a5
Clinical Value of the Systemic Immune Inflammation Index and PD-L1 Expression in Advanced NSCLC Treated with Pembrolizumab: Real-World Preliminary Study — Europe PMC PMID:42232607
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42232607
- DOI
- 10.32604/or.2026.077514
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:29:35.332Z
- SHA-256 of the archived text
79a7bd8d99026f91e658d0ab86ff4ce86f4a4f85adaf43bcfa4ede385c74b1bf- Stable URL of this page
https://metraipolis.com/documento/dc_4c141c5309a5
How to cite
Clinical Value of the Systemic Immune Inflammation Index and PD-L1 Expression in Advanced NSCLC Treated with Pembrolizumab: Real-World Preliminary Study — Europe PMC PMID:42232607 — Europe PMC (en), https://europepmc.org/article/MED/42232607 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4c141c5309a5 (Metraipolis archive dc_4c141c5309a5, sha256 79a7bd8d99026f91e658d0ab86ff4ce86f4a4f85adaf43bcfa4ede385c74b1bf)
BibTeX
@misc{dc4c141c5309a5,
title = {Clinical Value of the Systemic Immune Inflammation Index and PD-L1 Expression in Advanced NSCLC Treated with Pembrolizumab: Real-World Preliminary Study — Europe PMC PMID:42232607},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42232607},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4c141c5309a5; sha256 79a7bd8d99026f91e658d0ab86ff4ce86f4a4f85adaf43bcfa4ede385c74b1bf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42232607. Agents can read the archived copy with the MCP tool read_document.